Changes in concentrations of creatine and related metabolites, as well as GSH and GSSG, and the activities of creatine- and GSH-forming enzymes in tissues of the HSB are summarized in Supplementary Tables S1, S2, S3, and S4
And Lillys oral GLP-1, orforglipron, is expected to launch soon, signaling broader class expansion
6 Systemic manifestations Systemic manifestations are common and include flulike symptoms, fever, lymphadenopathy, and mucosal involvement (conjunctival, oropharyngeal, esophageal, and genital)
What else did others take away from the analysis
doi:10.1056/NEJMoa2403347 Kosiborod MN, Abildstrm SZ, Borlaug BA, et al
Consultado el 16 de enero de 2016